Author:
Jacobs Robert L.,Andrews Charles P.,Ramirez Daniel A.,Rather Cynthia G.,Harper Nathan,Jimenez Fabio,Martinez Hernan,Manoharan Muthu,Carrillo Andrew,Gerardi Margit,Esch Robert E.,He Weijing,Ahuja Sunil K.
Subject
Immunology,Immunology and Allergy
Reference15 articles.
1. U.S. Food and Drug Administration Center for Biologics Evaluation and Research: Allergenic Products Advisory Committee, May 12, 2011. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/AllergenicProductsAdvisoryCommittee/UCM258587.pdf. Accessed May 28, 2014.
2. Environmental exposure units: clinical trial design for validation;Togias,2010
3. Correlation between a pollen challenge chamber and a natural allergen exposure study design for eliciting ocular and nasal symptoms: early evidence supporting a paradigm shift in drug investigation?;Bernstein;J Allergy Clin Immunol,2012
4. The allergen challenge chamber: a valuable tool for optimizing the clinical development of pollen immunotherapy;Devillier;Allergy,2011
5. Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes;Jacobs;J Allergy Clin Immunol,2012
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献